Takeda Korea Pharmaceutical Appoints Lee Seon-jin as Head of Oncology Division

Seonjin Lee, General Manager of the Oncology Division at Takeda Korea

[Asia Economy Reporter Lee Gwan-joo] Takeda Korea announced on the 20th that Lee Seon-jin has been promoted and appointed as the head of the Oncology Business Unit (Oncology BU).

Lee, the newly appointed head, joined Takeda Korea in 2017 as a marketing manager for the Hemophilia Business Unit, where she developed creative marketing strategies and led the engagement of internal and external stakeholders to implement them.

She was recognized for her outstanding leadership skills, playing a pivotal role in improving the approach and perception of Takeda Korea’s hemophilia business. As the Launch & Digital Excellence Lead for the Asia-Pacific (APAC) region, she led product launches in the market and successfully executed projects by providing vision and direction for the digital transformation initiatives across APAC countries.

Moon Hee-seok, CEO of Takeda Korea, said, “This promotion is especially meaningful as it is the result of Takeda’s talent development program,” adding, “Takeda Korea will continue to do its best to nurture talent by supporting various programs for employees and enabling each individual to maximize their capabilities through career development plans.”

This content was produced with the assistance of AI translation services.